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Abstract
Background: Fibromyalgia syndrome (FMS) is a complex chronic condition that makes high demands on patients’
self-management skills. Thus, patient education is considered an important component of multimodal therapy, although
evidence regarding its effectiveness is scarce. The main objective of this study is to assess the effectiveness of an
advanced self-management patient education program for patients with FMS as compared to usual care in the
context of inpatient rehabilitation.
Methods/Design: We conducted a multicenter cluster randomized controlled trial in 3 rehabilitation clinics. Clusters
are groups of patients with FMS consecutively recruited within one week after admission. Patients of the intervention
group receive the advanced multidisciplinary self-management patient education program (considering new
knowledge on FMS, with a focus on transfer into everyday life), whereas patients in the control group receive
standard patient education programs including information on FMS and coping with pain. A total of 566 patients
are assessed at admission, at discharge and after 6 and 12 months, using patient reported questionnaires. Primary
outcomes are patients’ disease- and treatment-specific knowledge at discharge and self-management skills after
6 months. Secondary outcomes include satisfaction, attitudes and coping competences, health-promoting behavior,
psychological distress, health impairment and participation. Treatment effects between groups are evaluated using
multilevel regression analysis adjusting for baseline values.
Discussion: The study evaluates the effectiveness of a self-management patient education program for patients
with FMS in the context of inpatient rehabilitation in a cluster randomized trial. Study results will show whether
self-management patient education is beneficial for this group of patients.
Trial registration: German Clinical Trials Register, DRKS00008782, Registered 8 July 2015
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Background
This is a study protocol of a cluster randomized trial based
on CONSORT and SPIRIT recommendations [1, 2].
The fibromyalgia syndrome (FMS) is characterized by
chronic widespread pain and additional symptoms as
fatigue, unrefreshed sleep, cognitive symptoms and vari-
ous somatic symptoms [3]. About 2–7 % of the general
population are affected by FMS, with a higher prevalence
in women [4–6]. The disorder causes substantial burden
for the individual [7] and high socioeconomic costs
through increased healthcare utilization [8]. A study of a
German health insurance company estimated total yearly
costs to 4.331 €, thereof 3602 € direct costs [9]. Another
study calculated adjusted yearly direct costs of $2417
and indirect costs of $10.001 in Germany [10]. In an
US-sample, mean healthcare costs for FMS patients
were three times higher than for other patients [11]. Ac-
cording to FMS guidelines [12–14], treatment should be
multidisciplinary and combine different pharmacologic
and non-pharmacologic therapies, with self-management
patient education as one recommended component. Re-
search indicates that multicomponent therapy including
psychological and exercise therapy has positive effects
on key symptoms of FMS, self-efficacy and physical
fitness [15]. Information about the relative effectiveness
of different treatment components is scarce [16]. Meta-
analytical results show small but robust positive effects
of psychological treatments (including patient education)
for fibromyalgia [17]. There is limited evidence regarding
the effectiveness of self-management patient education
for patients with FMS. Comparison of studies is difficult
because of different contents and formats of education
programs and evaluation of multimodal programs with
different components [18–33]. Moreover, many studies
use some form of education as control (not as intervention)
condition or do not assess long-term effectiveness of
self-management education [34]. Further research is
needed to determine the independent effects of patient
education [35].
An existing German patient education program for pa-
tients with FMS in the medical rehabilitation system
[36] proved its worth over years, but there was a need to
revise it. It did not consider up-to-date knowledge about
FMS, especially the new national guideline [12], had
potential for didactical improvements and should be
advanced with regard to patients’ needs [37]. Further-
more, its effectiveness has not been evaluated so far.
Therefore, based on this program, an advanced self-
management patient education program was developed.
This new interactive, didactically revised program aims
to promote a biopsychosocial understanding and self-
management of the disease. It considers current know-
ledge on FMS and is consistent with the current national
guideline [12]. It has a focus on the transfer of pain and
stress management and physical activity into everyday
life. Although content and structure are similar to the
prior program, it includes more practical exercises and
emphasizes transfer into everyday life through action
planning.
The objective of this cluster randomized controlled
study is to evaluate this advanced self-management pa-
tient education program for patients with fibromyalgia
syndrome [38] in inpatient rehabilitation. The main
research questions are the short-, intermediate- and
long-term effectiveness of the self-management pro-
gram compared to usual care, in this case an active
control (standard patient education programs). We
hypothesize that the program is superior to usual care
regarding both disease- and treatment-specific knowledge
at discharge of rehabilitation and self-management com-
petence 6 months after rehabilitation (primary outcomes).
Additionally, we expect superior effectiveness regarding
satisfaction with the program, attitudes towards the illness
and coping competences, health-promoting behavior, psy-
chological distress, health impairment and participation
(secondary outcomes). The role of potential moderator
variables (e.g. age, psychological co-morbidity, duration of
disease) is examined in an exploratory manner.
Methods/Design
Study design and data collection
This study is a multicenter cluster randomized controlled
trial (RCT) conducted in three German inpatient rehabili-
tation clinics. Clusters are groups of patients with FMS
consecutively recruited within one week after admission to
the clinic. The superiority trial has two arms. Patients of
the intervention group (IG) receive the advanced self-
management patient education program. Patients of the
control group (CG) receive standard patient education pro-
grams including information on FMS and coping with pain
(usual care). Data are collected at admission (t1), discharge
(t2) and after 6 (t3) and 12 months (t4) with standardized
and self-developed patient-reported questionnaires. Add-
itionally, medical data are collected during rehabilitation.
Cluster randomization was chosen for practical reasons
(to have groups that are sufficiently large), for blinding
patients as to intervention conditions and to prevent
contamination between interventions. Clusters of pa-
tients are randomly assigned to the two intervention
conditions in a 1:1 ratio. For t1 and t2, patients receive
the questionnaire in the inpatient rehabilitation clinic. For
t3 and t4, patients receive the questionnaire by mail and
are reminded with a second letter if necessary. Figure 1
shows the study protocol diagram.
Ethical aspects
This study conforms to the principles of the Declaration
of Helsinki. It was approved by the Ethics Committee of
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the Faculty of Medicine, University of Würzburg, on
April 22, 2014 (reference number: 46/14). Participants
are informed about the study in the initial consultation
and additionally are provided an information sheet. Par-
ticipation is voluntary and based on written informed
consent. Patients are informed about their right to refuse
participation in the study or withdraw consent to partici-
pate without consequences for their treatment. They are
also informed about data protection through collecting
data using code numbers for each patient.
Participants
Considered for inclusion are adult patients in inpatient re-
habilitation clinics with the main diagnosis fibromyalgia
syndrome (ICD-10: M79.7). Exclusion criteria are insuffi-
cient German language ability, severe psychiatric comorbid-
ity which leads to inability to participate in an educational
group, cognitive impairment or not corrected severe visual
or hearing impairment. Patients with FMS are admitted to
the clinics every two weeks. All patients admitted during
this period of one week are eligible to build a cluster, with a
minimum of 3 participants per group.
Intervention
Inpatient rehabilitation in Germany for patients with
FMS is multimodal and includes medical treatment, ex-
ercise therapy, health education, psychological support,
relaxation and social counseling over a period of three (for
severe cases sometimes four) weeks. This trial compares a
self-management patient education group program to
standard patient education programs (usual care), both
within inpatient rheumatological rehabilitation centers.
Intervention group (IG). Participants in the interven-
tion group attend a disease-specific self-management pa-
tient education program ([38], see Table 1). It consists of
6 sessions of 90 min each and one (optional) preparing
session, all delivered in small groups (12 participants
maximum) of closed format. The program is manual-
based and led by physicians, psychologists and physio-
therapists, respectively. Methods are interactive, with
patients actively involved and different didactic methods
used (interactive short lectures, group discussion, prac-
tice, individual work). Materials include presentations,
flipchart, work sheets and patient information sheets.
Contents of the sessions include fibromyalgia-related
information (e.g. symptoms, diagnosis, course of disease,
causes and influencing factors, frequency), information
about treatment (e.g. treatment options, medication,
physical therapy, psychotherapy, risks and benefits of
alternative therapies), coping with pain and stress as well
as promotion of sustained physical activity. There is a
focus on both self-management and transfer into every-
day life through action planning. Evaluations by patients
performed during formative evaluation showed a high
Fig. 1 Study protocol diagram of data collection process
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satisfaction with the program [38]. All trainers are expe-
rienced with patients with FMS. Additionally, the
trainers receive a 1.5 day train-the-trainer course held by
project staff and a psychologist with experience in FMS-
education.
Control group (CG). Control condition is the treatment
as usual including education as delivered in the respective
clinic. In one cooperating clinic, usual care is the previ-
ously practiced, interactive patient education for fibro-
myalgia syndrome with 5 sessions (90 min each; content:
illness and treatment information, coping with pain and
stress, exercise therapy). Trainers are a psychologist, a
physician, a physiotherapist and an occupational therapist
or nutritionist. In the second cooperating clinic, patients
participate in a coping with pain group with 4 sessions
(90 min each; content: information about pain, coping
with pain, transfer into daily life) led by a psychologist,
physiotherapist and physician and receive a flyer about the
fibromyalgia syndrome. In the third cooperating clinic, pa-
tients are informed by 3 physician-delivered lectures
(60 min each) about chronic pain, fibromyalgia syndrome
and stress and may participate in educational group pro-
grams for pain or stress coping (each with 4 sessions of
45 min each, led by psychologists) or autogenic training,
as indicated. There are differences between the three con-
trol conditions, but they also have common characteris-
tics. They all include information about FMS and coping
with pain. In contrast to the intervention condition, con-
trol conditions do not explicitly consider the up-to-date
knowledge about FMS, the new guideline [12] and newly
recorded needs of patients with FMS [38]. They are partly
less interactive and less self-management-oriented as they
do not include action and coping planning and do not
have such a strong emphasis on transfer into everyday life.
Outcomes and Measures
In this study, the effects of the treatment conditions are
assessed at the individual level using patient-reported
outcomes. Different proximal and distal outcomes at dif-
ferent measurement points are used for evaluation [39].
The primary outcome is disease- and treatment-specific
knowledge at discharge of inpatient rehabilitation and pa-
tients’ subjective self-management competence 6 months
after rehabilitation. Secondary outcomes include treat-
ment satisfaction, attitudes towards the illness and coping
competences, health-promoting behavior, psychological
distress, health impairment and participation. For measur-
ing knowledge, a new measure was developed based on
the content of the patient education program (the same
information is also given in the control condition).
Acceptance of the disease and communication about the
disease with others are also measured with a self-
developed questionnaire. Both were pre-tested in a sample
of n = 91 patients with fibromyalgia, items were selected
due to difficulty and comprehensibility (knowledge) or re-
sults from factor analysis (acceptance and communica-
tion). The other outcomes are assessed by standardized,
validated measures. Detailed information concerning the
outcomes and questionnaires are shown in Table 2. It will
take about 45 min for the patient to fill out the question-
naires at each measurement point.
Additionally, potential moderator variables as sociode-
mographic parameters, duration of disease and social
support (subscale social integration and support of the
Health Education Impact Questionnaire heiQ [40]) are
assessed as reported by the patients. Medical data as
diagnoses, medication, ACR-criteria (diagnostic criteria
of the American College of Rheumatology [3]) or work-
ing ability are provided by the attending physicians.
Sample size
The needed sample size was calculated based on expected
effect size, power and design effect (intracluster correl-
ation, expected average cluster size, [41]). This calculation
comprises some uncertainties as size of ICC, actual cluster
size, effect sizes and dropout rates. There are no previous
Table 1 Structure of the advanced self-management patient education program for patients with fibromyalgia syndrome
Session Trainer
0 Introduction, questions and expectations (optional) Psychologist
1 The fibromyalgia syndrome – What does that mean? (symptoms, diagnosis, course, causes and influencing factors, frequency,
communication with health professionals)
Physician
2 How is the fibromyalgia syndrome treated? (treatment options, medication, physical therapy, psychotherapy, risks and benefits of
alternative therapies)
Physician
3 Dealing with pain (acute vs. chronic pain, development and sustainment of pain, consequences, relationships to depression and
anxiety, coping with pain)
Psychologist
4 Everything hurts! – Thus, why moving? (possibilities of physical activity, consequences, physical exercises, important principals of
training, action and coping planning)
Physiotherapist
5 Everything grows over my head! – Ways out of stress (types of stressors, development of stress, stress reaction and
consequences, relationship to pain, coping with stress, exercises)
Psychologist
6 Managing daily life (explaining the condition to others, goals for daily life, checking the action plans, improving sleep quality,
personal conclusion)
Psychologist
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studies in similar contexts with similar interventions and
outcomes which enable exact estimations. We assumed
small to medium effects (d = 0.3) in the primary outcome
due to the comparison with a control group that also gets
a comprehensive treatment. Thus, setting alpha risk to
0.05 and power to 0.8, a sample of 175 per group is
needed for two-tailed tests. Assuming an intraclass correl-
ation coefficient (ICC) of 0.01 and an average cluster size
of 6, the resulting design effect is 1.05, resulting in a
needed sample size of 184 per group. Thus, 566 partici-
pants have to be recruited, based on an estimated max-
imum dropout rate of 35 % during follow-up. Because
power to detect smaller effects between groups may be
too low, effect sizes will be reported.
Randomization, allocation concealment and blinding
External cluster-randomization is performed by the re-
search institute (central randomization) using a computer-
generated list of random numbers, ensuring a 1:1 ratio for
both treatment conditions. FMS patients are recruited
at admission to inpatient rehabilitation by study assis-
tants in the clinics and allocated to the next education
group (cluster). A new treatment condition starts every
two weeks. Allocation concealment will be attained by
providing information about allocation (by telephone or
email) only after a cluster has been recruited. Patients
are blinded regarding the allocated study arm. It is not
possible to blind staff in the rehabilitation clinics, espe-
cially those performing the educational interventions.
Statistical methods
All analyses are performed with SPSS for Windows. After
exploration of missing patterns, missing data in accordance
with missing at random assumptions will be imputed by a
multiple imputation procedure. T-tests for independent
variables are used for nonresponder- and dropout-analyses.
The evaluation of primary and secondary endpoints is car-
ried out according to the intention-to-treat-principle.
Before analyzing the combined data of the three clinics we
will confirm that 'clinic' is not a moderator variable. Treat-
ment effects between groups will be evaluated separately
for each follow-up time point using multilevel regression
analysis adjusting for baseline values [41–43]. Treatment
group is included in the models as fixed effect and individ-
uals are nested in clusters (education groups) as random
effects. Report of outcomes includes ICCs, statistical sig-
nificance (p < 0.05, 2-sided) and effect sizes [44] for differ-
ences between groups. For exploratory moderator analyses,
potential moderator variables are included as an additional
fixed factor or covariate, respectively.
Table 2 Outcomes, measures, assessment
Outcome Measure Assessment
t1 t2 t3 t4
Primary outcomes
Disease- and treatment-specific knowledge Self-developed questionnaire x x - x
Subjective self-management competence Health education impact questionnaire heiQ, German version [40], subscales
Skill and technique acquisition, Self-monitoring and insight
x x x x
Secondary outcomes
Treatment satisfaction Patient education satisfaction questionnaire [45] - x x x
Attitudes and coping competences:
Pain-related controllability Rheumatology Attitudes Index, German version [46] x x x x
Acceptance of the disease and
communication with others
Self-developed questionnaire x x x x
Behavior determinants for physical
activity and relaxation
HAPA-scales [47, 48] x x - -
Behavior:
Health-promoting behavior, active lifestyle Godin Leisure-Time Exercise Questionnaire [49], German modified version x - x x
Relaxation index [50] x - x x
Health education impact questionnaire heiQ, German version, subscales
Active engagement in life, Health-promoting activities
x - x x
Interaction in the health system Health education impact questionnaire heiQ, German version, subscale
Health service navigation
x - x x
Health impairment Fibromyalgia Impact Questionnaire German version, without the physical
functioning subscale, FIQ-G [51, 52]
x x x x
Psychological distress Short form of the Patient Health Questionnaire PHQ-4 [53] x x x x
Participation Fibromyalgia Participation Questionnaire FPQ [54] x - x x
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Discussion
Fibromyalgia syndrome is an impairing condition and cop-
ing with pain and other sequelae is an important issue in
its treatment. Thus, self-management patient education
aiming at coping with the condition in everyday life may
be an important component of treatment. Effectiveness of
such programs within a multimodal treatment is still un-
clear, however. This study will contribute to evidence in
that it will show whether an advanced patient education
program implemented in inpatient rehabilitation centers is
effective regarding disease- and treatment specific know-
ledge, subjective self-management competences and other
outcomes. Therefore, it is compared to standard patient
education programs (usual care). Outcomes are assessed
not only in the short term, but also over a period of one
year after rehabilitation. Multilevel analyses ensures the
consideration of the hierarchical data structure, preventing
misinterpretations due to dependency of individuals within
clusters. Cluster randomization blinds patients and pre-
vents contamination of the treatment. If the intervention
proves to be effective, it may be implemented in other
clinics and recommended to help satisfy the high need for
disease-related information and self-management support
of patients with FMS [38].
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